BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9456333)

  • 21. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations.
    Alldredge BK
    Neurology; 1999; 53(5 Suppl 2):S68-75. PubMed ID: 10496236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
    Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
    Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical issues in geriatric psychopharmacology.
    Tierney J
    J Indian Med Assoc; 1999 Apr; 97(4):145-7. PubMed ID: 10652900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive costs and benefits of psychotropic medications in older adults.
    Brooks JO; Hoblyn JC
    J Geriatr Psychiatry Neurol; 2007 Dec; 20(4):199-214. PubMed ID: 18004007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prescribing psychotropic drugs to patients aged 80 and over].
    Hilleret H; Falconnet C; Le Saint L; Perrenoud JJ; Michel JP; Vogt-Ferrier N
    Rev Med Suisse; 2008 Nov; 4(178):2405-8, 2410-1. PubMed ID: 19051628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic considerations in the geriatric patient.
    Walinsky MD
    Clin Podiatr Med Surg; 1993 Apr; 10(2):221-30. PubMed ID: 8481880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoiding psychotropic drug interactions in the cardiovascular patient.
    DeVane CL; Markowitz JS
    Bull Menninger Clin; 2000; 64(1):49-59. PubMed ID: 10695159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing in older people.
    Le Couteur DG; Hilmer SN; Glasgow N; Naganathan V; Cumming RG
    Aust Fam Physician; 2004 Oct; 33(10):777-81. PubMed ID: 15532150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?
    Zhou H
    J Clin Pharmacol; 2006 Nov; 46(11):1268-89. PubMed ID: 17050792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic drugs and the aging patient.
    Pollock BG
    Geriatrics; 1998 Sep; 53 Suppl 1():S20-4. PubMed ID: 9745631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics.
    Strain JJ; Caliendo G; Himelein C
    Psychooncology; 1998; 7(4):321-32. PubMed ID: 9741071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geropharmacology: a primer for advanced practice acute care and critical care nurses, part I.
    Ferrario CG
    AACN Adv Crit Care; 2008; 19(1):23-35; quiz 36-7. PubMed ID: 18418102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic drug interactions with newer antipsychotics: a comparative review.
    Spina E; de Leon J
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):4-22. PubMed ID: 17214606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relevance of pharmacokinetics to prescribing in psychiatry.
    Ashton H; Harrison R
    Br J Hosp Med; 1994 Jun 1-14; 51(11):573, 576-80. PubMed ID: 7952746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Grapefruit juice interactions with psychotropic drugs: advantages and potential risk].
    Pawełczyk T; Kłoszewska I
    Przegl Lek; 2008; 65(2):92-5. PubMed ID: 18663908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of psychotropic drugs in epilepsy: what every neurologist should know.
    Kanner AM
    Semin Neurol; 2008 Jul; 28(3):379-88. PubMed ID: 18777484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology.
    Carson SW; Ousmanou AD; Hoyler SL
    Psychopharmacol Bull; 2002; 36(1):67-81. PubMed ID: 12397848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinically significant drug interactions in HIV-infected patients].
    Weisser M; Battegay M
    Ther Umsch; 1998 May; 55(5):310-22. PubMed ID: 9643129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in effectiveness of psychotherapeutic drug level monitoring program after lessening pharmacy involvement.
    Cyr M; Dorson PG; Crismon ML
    Hosp Pharm; 1995 Feb; 30(2):116, 118-9. PubMed ID: 10140524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.